Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
RAR-related orphan receptor gamma | 11 | 0 | 0 | 11 |
ATAD5 protein, partial | 5 | 0 | 0 | 5 |
GLS protein | 4 | 0 | 0 | 4 |
Microtubule-associated protein tau | 5 | 0 | 0 | 5 |
Smad3 | 4 | 0 | 0 | 4 |
aldehyde dehydrogenase 1 family, member A1 | 8 | 0 | 0 | 8 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
nuclear receptor subfamily 1, group I, member 3 | 7 | 0 | 0 | 7 |
progesterone receptor | 9 | 0 | 0 | 9 |
EWS/FLI fusion protein | 4 | 0 | 0 | 4 |
retinoic acid nuclear receptor alpha variant 1 | 8 | 0 | 0 | 8 |
retinoid X nuclear receptor alpha | 6 | 0 | 0 | 6 |
estrogen-related nuclear receptor alpha | 11 | 0 | 0 | 11 |
estrogen nuclear receptor alpha | 12 | 0 | 0 | 12 |
peroxisome proliferator activated receptor gamma | 8 | 0 | 0 | 8 |
aryl hydrocarbon receptor | 4 | 0 | 0 | 4 |
chromobox protein homolog 1 | 5 | 0 | 0 | 5 |
thyroid hormone receptor beta isoform 2 | 10 | 0 | 0 | 10 |
peripheral myelin protein 22 | 7 | 0 | 0 | 7 |
cytochrome P450 3A4 isoform 1 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit pi | 6 | 0 | 0 | 6 |
ATP-binding cassette sub-family C member 3 | 0 | 11 | 0 | 11 |
Multidrug resistance-associated protein 4 | 0 | 11 | 0 | 11 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 12 | 0 | 2 | 0 | 4 |
UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
Bile salt export pump | 0 | 2 | 0 | 2 |
Voltage-dependent calcium channel gamma-2 subunit | 7 | 0 | 0 | 7 |
Bile salt export pump | 0 | 14 | 0 | 14 |
Cytochrome P450 2B1 | 0 | 0 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 2 | 0 | 4 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 5 |
Myoglobin | 0 | 1 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 0 | 1 | 2 |
Cytochrome P450 1A2 | 0 | 0 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 2 | 0 | 3 |
Cytochrome P450 3A4 | 0 | 4 | 0 | 4 |
Cytochrome P450 2D6 | 0 | 2 | 0 | 2 |
Cytochrome P450 2C9 | 0 | 2 | 0 | 2 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 6 | 0 | 0 | 6 |
Sulfotransferase 1A1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 6 | 0 | 1 | 7 |
UDP-glucuronosyltransferase 1-6 | 0 | 0 | 0 | 1 |
Glutamate receptor 2 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 6 | 0 | 0 | 6 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 2 | 0 | 4 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 6 | 0 | 2 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 6 | 0 | 0 | 6 |
Carbonic anhydrase 5A, mitochondrial | 0 | 2 | 0 | 4 |
Prostaglandin G/H synthase 2 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 2 | 0 | 4 |
Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
Cytochrome P450 2J2 | 0 | 3 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 6 | 0 | 1 | 7 |
Gamma-aminobutyric acid receptor subunit beta-3 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit beta-2 | 6 | 0 | 1 | 7 |
Carbonic anhydrase 9 | 0 | 2 | 0 | 4 |
GABA theta subunit | 6 | 0 | 0 | 6 |
Canalicular multispecific organic anion transporter 1 | 0 | 11 | 0 | 11 |
Carbonic anhydrase 15 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 13 | 0 | 2 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit epsilon | 6 | 0 | 0 | 6 |
Carbonic anhydrase 14 | 0 | 2 | 0 | 4 |
Carbonic anhydrase 5B, mitochondrial | 0 | 2 | 0 | 4 |
toxin B | 0 | 0 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 2 | 0 | 0 | 2 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
Chain A, 2-oxoglutarate Oxygenase | 3 | 0 | 0 | 3 |
Luciferase | 3 | 0 | 0 | 3 |
acetylcholinesterase | 4 | 0 | 0 | 4 |
phosphopantetheinyl transferase | 5 | 0 | 0 | 5 |
hypoxia-inducible factor 1 alpha subunit | 6 | 0 | 0 | 6 |
TDP1 protein | 9 | 0 | 0 | 9 |
GLI family zinc finger 3 | 9 | 0 | 0 | 9 |
AR protein | 14 | 0 | 0 | 14 |
estrogen receptor 2 (ER beta) | 8 | 0 | 0 | 8 |
regulator of G-protein signaling 4 | 4 | 0 | 0 | 4 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 7 | 0 | 0 | 7 |
farnesoid X nuclear receptor | 7 | 0 | 0 | 7 |
cytochrome P450 2D6 | 5 | 0 | 0 | 5 |
peroxisome proliferator-activated receptor delta | 6 | 0 | 0 | 6 |
euchromatic histone-lysine N-methyltransferase 2 | 9 | 0 | 0 | 9 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 4 | 0 | 0 | 4 |
thyroid stimulating hormone receptor | 8 | 0 | 0 | 8 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 7 | 0 | 0 | 7 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 8 | 0 | 0 | 8 |
Histone H2A.x | 6 | 0 | 0 | 6 |
cytochrome P450 2D6 isoform 1 | 3 | 0 | 0 | 3 |
cellular tumor antigen p53 isoform a | 2 | 0 | 0 | 2 |
cytochrome P450 2C19 precursor | 3 | 0 | 0 | 3 |
cytochrome P450 2C9 precursor | 2 | 0 | 0 | 2 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 2 | 0 | 0 | 2 |
potassium voltage-gated channel subfamily H member 2 isoform d | 9 | 0 | 0 | 9 |
mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 11 | 0 | 0 | 11 |
nuclear receptor ROR-gamma isoform 1 | 4 | 0 | 0 | 4 |
geminin | 9 | 0 | 0 | 9 |
lethal factor (plasmid) | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 11 | 0 | 0 | 11 |
Solute carrier family 22 member 1 | 0 | 3 | 0 | 4 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
Cellular tumor antigen p53 | 8 | 0 | 0 | 8 |
Integrin beta-3 | 1 | 0 | 0 | 1 |
Integrin alpha-IIb | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 1 | 3 |
Tryptophan 5-hydroxylase 1 | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 10 | 2 | 14 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 1 | 3 |
Alpha-1B adrenergic receptor | 0 | 4 | 0 | 4 |
D | 0 | 3 | 0 | 3 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 9 | 1 | 10 |
Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
D(1A) dopamine receptor | 0 | 10 | 2 | 14 |
D(4) dopamine receptor | 0 | 4 | 1 | 6 |
D(1B) dopamine receptor | 0 | 2 | 0 | 3 |
Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 13 | 0 | 13 |
5-hydroxytryptamine receptor 1B | 0 | 9 | 1 | 10 |
5-hydroxytryptamine receptor 1D | 0 | 2 | 1 | 3 |
D(4) dopamine receptor | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 1F | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 6 | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 7 | 0 | 3 | 1 | 4 |
5-hydroxytryptamine receptor 5A | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 5B | 0 | 2 | 1 | 3 |
D(3) dopamine receptor | 0 | 12 | 1 | 14 |
5-hydroxytryptamine receptor 3A | 0 | 2 | 1 | 3 |
Alpha-1A adrenergic receptor | 0 | 5 | 0 | 5 |
Histamine H2 receptor | 3 | 1 | 1 | 6 |
5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
Spike glycoprotein | 6 | 1 | 2 | 9 |
D(2) dopamine receptor | 0 | 2 | 2 | 4 |
E3 ubiquitin-protein ligase Mdm2 | 0 | 1 | 0 | 1 |
D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 2 | 1 | 3 |
D | 0 | 2 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 4 | 0 | 0 | 4 |
Ataxin-2 | 6 | 0 | 0 | 6 |
Sigma non-opioid intracellular receptor 1 | 0 | 11 | 0 | 11 |
5-hydroxytryptamine receptor 3B | 0 | 2 | 1 | 3 |
ATP-dependent phosphofructokinase | 5 | 0 | 0 | 5 |
Chain A, Beta-lactamase | 5 | 0 | 0 | 5 |
glp-1 receptor, partial | 2 | 0 | 0 | 2 |
SMAD family member 2 | 4 | 0 | 0 | 4 |
Fumarate hydratase | 2 | 0 | 0 | 2 |
USP1 protein, partial | 4 | 0 | 0 | 4 |
SMAD family member 3 | 4 | 0 | 0 | 4 |
caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
glucocorticoid receptor [Homo sapiens] | 7 | 0 | 0 | 7 |
pregnane X nuclear receptor | 5 | 0 | 0 | 5 |
polyprotein | 2 | 0 | 0 | 2 |
67.9K protein | 5 | 0 | 0 | 5 |
glucocerebrosidase | 3 | 0 | 0 | 3 |
bromodomain adjacent to zinc finger domain 2B | 4 | 0 | 0 | 4 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 4 | 0 | 0 | 4 |
caspase-3 | 2 | 0 | 0 | 2 |
IDH1 | 4 | 0 | 0 | 4 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
activating transcription factor 6 | 5 | 0 | 0 | 5 |
thyrotropin-releasing hormone receptor | 2 | 0 | 0 | 2 |
Caspase-7 | 2 | 0 | 0 | 2 |
Spike glycoprotein | 0 | 1 | 2 | 3 |
Replicase polyprotein 1ab | 0 | 1 | 2 | 3 |
lysosomal alpha-glucosidase preproprotein | 4 | 0 | 0 | 4 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 3 | 0 | 0 | 3 |
caspase-3 | 2 | 0 | 0 | 2 |
heat shock protein beta-1 | 4 | 0 | 0 | 4 |
huntingtin isoform 2 | 3 | 0 | 0 | 3 |
ubiquitin-conjugating enzyme E2 N | 0 | 2 | 0 | 2 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
plasminogen precursor | 1 | 0 | 0 | 1 |
urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
survival motor neuron protein isoform d | 3 | 0 | 0 | 3 |
Transmembrane protease serine 2 | 0 | 1 | 2 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 4 | 0 | 10 | 0 | 10 |
Polycomb protein EED | 0 | 2 | 0 | 2 |
Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
Interferon beta | 5 | 0 | 0 | 5 |
HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 1 | 1 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Fyn | 0 | 2 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
Procathepsin L | 0 | 1 | 2 | 3 |
Aldo-keto reductase family 1 member B1 | 0 | 12 | 0 | 12 |
Muscarinic acetylcholine receptor M2 | 0 | 11 | 2 | 13 |
Muscarinic acetylcholine receptor M4 | 0 | 14 | 2 | 16 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 12 | 2 | 14 |
Alpha-2A adrenergic receptor | 0 | 10 | 0 | 10 |
Neuronal acetylcholine receptor subunit alpha-4 | 4 | 0 | 0 | 4 |
Replicase polyprotein 1a | 0 | 1 | 2 | 3 |
Replicase polyprotein 1ab | 0 | 1 | 2 | 3 |
Replicase polyprotein 1ab | 0 | 1 | 2 | 3 |
Adenosine receptor A3 | 0 | 2 | 0 | 2 |
Replicase polyprotein 1ab | 0 | 3 | 2 | 5 |
Muscarinic acetylcholine receptor M1 | 0 | 15 | 2 | 17 |
Neuronal acetylcholine receptor subunit beta-2 | 4 | 0 | 0 | 4 |
Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-2B adrenergic receptor | 0 | 10 | 0 | 10 |
Alpha-2C adrenergic receptor | 0 | 10 | 0 | 10 |
Muscarinic acetylcholine receptor M3 | 0 | 12 | 2 | 14 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
Substance-K receptor | 0 | 4 | 0 | 4 |
Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
Sodium-dependent noradrenaline transporter | 0 | 14 | 1 | 15 |
Histamine H2 receptor | 0 | 7 | 2 | 9 |
Alpha-1D adrenergic receptor | 0 | 11 | 0 | 11 |
Substance-P receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 10 | 0 | 10 |
Somatostatin receptor type 2 | 0 | 1 | 0 | 1 |
Somatostatin receptor type 4 | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 10 | 1 | 11 |
Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
Somatostatin receptor type 3 | 0 | 1 | 0 | 1 |
Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
Somatostatin receptor type 5 | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 14 | 2 | 16 |
Mu-type opioid receptor | 0 | 4 | 0 | 4 |
Delta-type opioid receptor | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 12 | 0 | 12 |
Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 6 | 0 | 8 | 0 | 8 |
Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
Inositol monophosphatase 1 | 4 | 0 | 0 | 4 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 3 | 0 | 3 |
Sodium-dependent dopamine transporter | 0 | 10 | 1 | 11 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 6 | 1 | 7 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
Angiotensin-converting enzyme 2 | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 2 | 2 | 4 |
Heparanase | 0 | 0 | 1 | 1 |
thioredoxin reductase | 6 | 0 | 0 | 6 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
Bloom syndrome protein isoform 1 | 3 | 0 | 0 | 3 |
D(1A) dopamine receptor | 4 | 0 | 0 | 4 |
histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 1 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 3 | 0 | 0 | 3 |
Chain A, Cruzipain | 2 | 0 | 0 | 2 |
endonuclease IV | 2 | 0 | 0 | 2 |
chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
Estrogen receptor 1 | 0 | 1 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 2 | 0 | 0 | 2 |
PINK1 | 1 | 0 | 0 | 1 |
G | 1 | 0 | 0 | 1 |
Parkin | 2 | 0 | 0 | 2 |
estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
flap endonuclease 1 | 1 | 0 | 0 | 1 |
snurportin-1 | 1 | 0 | 0 | 1 |
GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
M-phase phosphoprotein 8 | 3 | 0 | 0 | 3 |
muscarinic acetylcholine receptor M1 | 2 | 0 | 0 | 2 |
neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
Cruzipain | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
Type IV secretion-like conjugative transfer relaxase protein TraI | 0 | 1 | 0 | 1 |
72 kDa type IV collagenase | 0 | 1 | 0 | 1 |
Stromelysin-1 | 0 | 1 | 0 | 1 |
Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
Macrophage metalloelastase | 0 | 1 | 0 | 1 |
Phenylethanolamine N-methyltransferase | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 1 | 1 | 2 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 0 | 1 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
STAT3, partial | 0 | 2 | 0 | 2 |
nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
NPC intracellular cholesterol transporter 1 precursor | 3 | 0 | 0 | 3 |
thyroid hormone receptor beta isoform a | 1 | 0 | 0 | 1 |
ras-related protein Rab-9A | 3 | 0 | 0 | 3 |
signal transducer and activator of transcription 1-alpha/beta isoform alpha | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 3 | 0 | 4 |
Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 3 | 0 | 4 |
Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 2 | 0 | 3 |
Sodium/potassium-transporting ATPase subunit beta-2 | 0 | 2 | 0 | 3 |
Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 3 | 0 | 4 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 2 | 0 | 3 |
Sodium/potassium-transporting ATPase subunit gamma | 0 | 2 | 0 | 3 |
Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 2 | 0 | 3 |
Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 2 |
Histamine H1 receptor | 0 | 2 | 2 | 5 |
Histamine H1 receptor | 0 | 3 | 1 | 4 |
Histamine H3 receptor | 0 | 1 | 0 | 2 |
Albumin | 0 | 1 | 0 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
Holo-[acyl-carrier-protein] synthase | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
GALC protein | 2 | 0 | 0 | 2 |
apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 3 | 0 | 0 | 3 |
Solute carrier family 22 member 2 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 2 |
Plasma kallikrein | 0 | 0 | 0 | 1 |
Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
Adenosine receptor A1 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
Adenosine receptor A2a | 0 | 0 | 0 | 1 |
Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 1 |
Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 1 |
Histamine H3 receptor | 0 | 1 | 2 | 3 |
Chain A, ADENOSINE DEAMINASE | 0 | 1 | 0 | 1 |
Chain A, ADENOSINE DEAMINASE | 0 | 1 | 0 | 1 |
Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 2 | 0 | 0 | 2 |
glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
Purine nucleoside phosphorylase | 0 | 0 | 0 | 1 |
Adenosylhomocysteinase | 0 | 1 | 0 | 2 |
Adenosine deaminase | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Translocator protein | 0 | 1 | 0 | 1 |
Chain H, Igg2b-kappa 40-50 Fab (heavy Chain) | 0 | 1 | 0 | 1 |
Chain L, Igg2b-kappa 40-50 Fab (light Chain) | 0 | 1 | 0 | 1 |
Chain A, Na, K-ATPase alpha subunit | 0 | 0 | 1 | 1 |
PPM1D protein | 1 | 0 | 0 | 1 |
Kruppel-like factor 5 | 0 | 1 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 5 | 0 | 5 |
Solute carrier organic anion transporter family member 1A1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
MCOLN3 protein | 0 | 0 | 1 | 1 |
transient receptor potential cation channel, subfamily N, member 1 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 3 | 0 | 3 |
Muscarinic acetylcholine receptor M4 | 0 | 3 | 0 | 3 |
Muscarinic acetylcholine receptor M5 | 0 | 3 | 0 | 3 |
Muscarinic acetylcholine receptor M2 | 0 | 4 | 1 | 5 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor DM1 | 0 | 1 | 0 | 1 |
Mineralocorticoid receptor | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 0 | 1 | 1 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
Vpr | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
Snq2p | 0 | 0 | 0 | 1 |
serine/threonine-protein kinase mTOR isoform 1 | 2 | 0 | 0 | 2 |
Major prion protein | 0 | 0 | 1 | 1 |
Calmodulin-1 | 0 | 1 | 0 | 1 |
Trypanothione reductase | 0 | 2 | 0 | 2 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
Calmodulin | 0 | 0 | 1 | 1 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
Thrombopoietin | 1 | 0 | 0 | 1 |
arylsulfatase A | 1 | 0 | 0 | 1 |
XBP1 | 0 | 1 | 0 | 1 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
DNA damage-inducible transcript 3 protein | 0 | 1 | 0 | 1 |
DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
Transcriptional activator protein LuxR | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
C-C chemokine receptor type 5 | 0 | 2 | 0 | 2 |
Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |